Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for "Medical Properties Trust SEC filings explained simply"? Operating a hospital REIT means every 10-K is packed with rent coverage ratios, operator credit metrics and lease escalation clauses鈥攄etails that make Medical Properties Trust (MPW) disclosures especially dense for investors who just want to know whether cash flow is secure. Stock Titan鈥檚 AI reads each document the moment it hits EDGAR and turns the legalese into plain English.
Need the latest Medical Properties Trust quarterly earnings report 10-Q filing or yesterday鈥檚 8-K on tenant restructuring? They鈥檙e here, alongside:
- Medical Properties Trust insider trading Form 4 transactions delivered in real-time
- Medical Properties Trust annual report 10-K simplified with rent coverage highlights
- Medical Properties Trust proxy statement executive compensation breakdowns
- Medical Properties Trust 8-K material events explained
- understanding Medical Properties Trust SEC documents with AI鈥攃oncise summaries, red-flag alerts and side-by-side historical comparisons
Whether you鈥檙e tracking Medical Properties Trust Form 4 insider transactions real-time before dividend announcements, assessing operator liquidity through a Medical Properties Trust earnings report filing analysis, or learning how sale-leasebacks flow through the balance sheet, our platform keeps every answer a click away. Comprehensive coverage, AI-powered summaries and instant alerts mean you spend minutes鈥攏ot hours鈥攅xtracting insights that drive decisions.
Medical Properties Trust, Inc. filed a prospectus supplement dated August 11, 2025 establishing an at-the-market equity program to offer up to $500,000,000 of common stock (NYSE: MPW). The offering is being conducted under an equity distribution agreement with multiple investment banks that may act as agents, forward sellers or principals, and the agents may receive up to 2% in commissions. The supplement states the last reported NYSE sale price was $4.08 per share on August 8, 2025.
The company intends to contribute net proceeds to its operating partnership for general corporate purposes, including repayment of borrowings under its revolving credit and term loan facilities and acquiring healthcare properties. MPT reported a portfolio of 392 properties leased or loaned to 53 tenants as of June 30, 2025 (174 general acute care hospitals, 69 behavioral health, 128 post-acute, 21 freestanding ER/urgent care), with ~4% in development or not leased and no single property >2% of total assets. The prospectus highlights material risks: potential dilution from forward sale transactions, substantial cash payment obligations on cash settlement, uncertain U.S. federal tax treatment of cash-settled forwards (with potential REIT qualification implications), recent dividend reductions in 2024 and 2025, and ownership restrictions capped at 9.8% to preserve REIT status.
Medical Properties Trust, Inc. (MPW) reported combined quarterly results through June 30, 2025 showing growth in total assets to $15.15 billion from $14.29 billion while recording a consolidated net loss of $98.1 million for the three months and $216.1 million for the six months. Total revenues declined to $240.4 million in Q2 2025 from $266.6 million a year earlier, driven by lower rent billed and reduced income from financing leases. Interest expense rose to $129.7 million for the quarter, reflecting higher borrowing costs, while cash and cash equivalents increased to $509.8 million.
Other operating items materially affected results: non-cash fair value adjustments, impairment charges and equity investment swings produced $95.1 million of other expense in Q2 and $198.2 million for six months. The company closed $1.5 billion of USD and 鈧�1.0 billion of Euro senior secured notes due 2032 in February 2025 and used proceeds to redeem certain unsecured notes and pay down revolving borrowings, leaving net debt of $9.65 billion. The board declared dividends of $0.08 per share for the quarter ($0.16 year-to-date) after a prior $0.30 per-quarter level in 2024. Foreign currency translation produced a large $210.8 million gain in Q2, driving total comprehensive income for the quarter to $112.5 million despite the operating loss.
FAQ
What is the current stock price of Medical Prop (MPW)?
What is the market cap of Medical Prop (MPW)?
